{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:40:26Z","timestamp":1791974426361,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/gt.2014.115","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T11:36:49Z","timestamp":1418297809000},"page":"116-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates"],"prefix":"10.1038","volume":"22","author":[{"given":"M A","family":"Kotterman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Strazzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J G","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W H","family":"Merigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D V","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,11]]},"reference":[{"key":"BFgt2014115_CR1","volume-title":"Fields\u2019 Virology","author":"DM Knipe","year":"2007","unstructured":"Knipe DM, Howley PM . Fields\u2019 Virology. Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007."},{"key":"BFgt2014115_CR2","doi-asserted-by":"publisher","first-page":"10220","DOI":"10.1073\/pnas.1001673107","volume":"107","author":"F Sonntag","year":"2010","unstructured":"Sonntag F, Schmidt K, Kleinschmidt JA . A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc Natl Acad Sci USA 2010; 107: 10220\u201310225.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2014115_CR3","doi-asserted-by":"publisher","first-page":"12686","DOI":"10.1128\/JVI.05359-11","volume":"85","author":"F Sonntag","year":"2011","unstructured":"Sonntag F, K\u00f6ther K, Schmidt K, Weghofer M, Raupp C, Nieto K et al. The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes. J Virol 2011; 85: 12686\u201312697.","journal-title":"J Virol"},{"key":"BFgt2014115_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev.bioeng.10.061807.160514","volume":"10","author":"DV Schaffer","year":"2008","unstructured":"Schaffer D V, Koerber JT, Lim K . Molecular engineering of viral gene delivery vehicles. Annu Rev Biomed Eng 2008; 10: 169\u2013194.","journal-title":"Annu Rev Biomed Eng"},{"key":"BFgt2014115_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","volume":"14","author":"Z Wu","year":"2006","unstructured":"Wu Z, Asokan A, Samulski RJ . Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther 2006; 14: 316\u2013327.","journal-title":"Mol Ther"},{"key":"BFgt2014115_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.gt.3302233","volume":"11","author":"TR Flotte","year":"2004","unstructured":"Flotte TR . Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors. Gene Ther 2004; 11: 805\u2013810.","journal-title":"Gene Ther"},{"key":"BFgt2014115_CR7","unstructured":"Gene Therapy Clinical Trials Worldwide. J. Gene Med. 2014. http:\/\/www.abedia.com\/wiley\/ (accessed 18 March 2014)."},{"key":"BFgt2014115_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1089\/hum.2008.107","volume":"19","author":"WW Hauswirth","year":"2008","unstructured":"Hauswirth WW, Aleman TS, Kaushal S, Cideciyan A V, Schwartz SB, Wang L et al. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther 2008; 19: 979\u2013990.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1089\/hum.2009.086","volume":"20","author":"AV Cideciyan","year":"2009","unstructured":"Cideciyan A V, Hauswirth WW, Aleman TS, Kaushal S, Schwartz SB, Boye SL et al. Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum Gene Ther 2009; 20: 999\u20131004.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR10","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","volume":"358","author":"JWB Bainbridge","year":"2008","unstructured":"Bainbridge JWB, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K et al. Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis. N Engl J Med 2008; 358: 2231\u20132239.","journal-title":"N Engl J Med"},{"key":"BFgt2014115_CR11","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"A Maguire","year":"2008","unstructured":"Maguire A, Simonelli F . Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis. N Engl J Med 2008; 358: 2240\u20132248.","journal-title":"N Engl J Med"},{"key":"BFgt2014115_CR12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","volume":"374","author":"AM Maguire","year":"2009","unstructured":"Maguire AM, High K a, Auricchio A, Wright JF, Pierce E a, Testa F et al. Age-dependent effects of RPE65 gene therapy for Leber\u2019s congenital amaurosis: a phase 1 dose-escalation trial. Lancet 2009; 374: 1597\u20131605.","journal-title":"Lancet"},{"key":"BFgt2014115_CR13","doi-asserted-by":"publisher","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","volume":"4","author":"J Bennett","year":"2012","unstructured":"Bennett J, Ashtari M, Wellman J, Marshall K a, Cyckowski LL, Chung DC et al. AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med 2012; 4: 120ra15.","journal-title":"Sci Transl Med"},{"key":"BFgt2014115_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archophthalmol.2011.298","volume":"130","author":"SG Jacobson","year":"2012","unstructured":"Jacobson SG, Cideciyan A V, Ratnakaram R, Heon E, Schwartz SB, Roman AJ et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 2012; 130: 9\u201324.","journal-title":"Arch Ophthalmol"},{"key":"BFgt2014115_CR15","first-page":"2117","volume":"6736","author":"RE MacLaren","year":"2014","unstructured":"MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial. Lancet 2014; 6736: 2117\u20132120.","journal-title":"Lancet"},{"key":"BFgt2014115_CR16","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1038\/mt.2009.184","volume":"17","author":"JT Koerber","year":"2009","unstructured":"Koerber JT, Klimczak R, Jang J-H, Dalkara D, Flannery JG, Schaffer DV . Molecular evolution of adeno-associated virus for enhanced glial gene delivery. Mol Ther 2009; 17: 2088\u20132095.","journal-title":"Mol Ther"},{"key":"BFgt2014115_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/mt.2008.269","volume":"17","author":"H Petrs-Silva","year":"2009","unstructured":"Petrs-Silva H, Dinculescu A, Li Q, Min S-H, Chiodo V, Pang J-J et al. High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther 2009; 17: 463\u2013471.","journal-title":"Mol Ther"},{"key":"BFgt2014115_CR18","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1167\/iovs.07-1110","volume":"49","author":"TS Aleman","year":"2008","unstructured":"Aleman TS, Cideciyan A V, Sumaroka A, Windsor EAM, Herrera W, White DA et al. Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations. Invest Ophthalmol Vis Sci 2008; 49: 1580\u20131590.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt2014115_CR19","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1167\/iovs.08-2696","volume":"50","author":"SG Jacobson","year":"2009","unstructured":"Jacobson SG, Aleman TS, Cideciyan A V, Roman AJ, Sumaroka A, Windsor EAM et al. Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations. Invest Ophthalmol Vis Sci 2009; 50: 2368\u20132375.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt2014115_CR20","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1167\/iovs.08-3122","volume":"50","author":"SG Jacobson","year":"2009","unstructured":"Jacobson SG, Aleman TS, Sumaroka A, Cideciyan A V, Roman AJ, Windsor EAM et al. Disease boundaries in the retina of patients with Usher syndrome caused by MYO7A gene mutations. Invest Ophthalmol Vis Sci 2009; 50: 1886\u20131894.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt2014115_CR21","first-page":"867","volume":"12","author":"T Nakazawa","year":"2006","unstructured":"Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, Skondra D et al. Characterization of cytokine responses to retinal detachment in rats. Mol Vis 2006; 12: 867\u2013878.","journal-title":"Mol Vis"},{"key":"BFgt2014115_CR22","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1167\/iovs.06-1398","volume":"48","author":"T Nakazawa","year":"2007","unstructured":"Nakazawa T, Takeda M, Lewis GP, Cho K-S, Jiao J, Wilhelmsson U et al. Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin. Invest Ophthalmol Vis Sci 2007; 48: 2760\u20132768.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt2014115_CR23","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/gt.2009.61","volume":"16","author":"TK Park","year":"2009","unstructured":"Park TK, Wu Z, Kjellstrom S, Zeng Y, Bush RA, Sieving PA et al. Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse. Gene Ther 2009; 16: 916\u2013926.","journal-title":"Gene Ther"},{"key":"BFgt2014115_CR24","doi-asserted-by":"publisher","first-page":"e7467","DOI":"10.1371\/journal.pone.0007467","volume":"4","author":"RR Klimczak","year":"2009","unstructured":"Klimczak RR, Koerber JT, Dalkara D, Flannery JG, Schaffer DV . A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat M\u00fcller cells. PLoS One 2009; 4: e7467.","journal-title":"PLoS One"},{"key":"BFgt2014115_CR25","doi-asserted-by":"publisher","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","volume":"5","author":"D Dalkara","year":"2013","unstructured":"Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH et al. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med 2013; 5: 189ra76.","journal-title":"Sci Transl Med"},{"key":"BFgt2014115_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342\u2013347.","journal-title":"Nat Med"},{"key":"BFgt2014115_CR27","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1161\/ATVBAHA.108.175620","volume":"28","author":"ES Stroes","year":"2008","unstructured":"Stroes ES, Nierman MC, Meulenberg JJ, Franssen R, Twisk J, Henny CP et al. Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients. Arterioscler Thromb Vasc Biol 2008; 28: 2303\u20132304.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFgt2014115_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1089\/hum.2009.182","volume":"21","author":"S Boutin","year":"2010","unstructured":"Boutin S, Monteilhet V, Veron P, Leborgne C, Benveniste O, Montus MF et al. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum Gene Ther 2010; 21: 704\u2013712.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/mt.2009.245","volume":"18","author":"L Wang","year":"2010","unstructured":"Wang L, Calcedo R, Wang H, Bell P, Grant R, Vandenberghe LH et al. The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques. Mol Ther 2010; 18: 126\u2013134.","journal-title":"Mol Ther"},{"key":"BFgt2014115_CR30","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","volume":"365","author":"AC Nathwani","year":"2011","unstructured":"Nathwani AC, Tuddenham EGD, Rangarajan S, Rosales C, McIntosh J, Linch DC et al. Adenovirus-associated virus vector\u2013mediated gene transfer in hemophilia B. N Engl J Med 2011; 365: 2357\u20132365.","journal-title":"N Engl J Med"},{"key":"BFgt2014115_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","volume":"15","author":"BE Jaski","year":"2009","unstructured":"Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial. J Card Fail 2009; 15: 171\u2013181.","journal-title":"J Card Fail"},{"key":"BFgt2014115_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1023\/B:JOCI.0000019781.64421.5c","volume":"24","author":"V Cottard","year":"2004","unstructured":"Cottard V, Valvason C, Falgarone G, Lutomski D, Boissier M-C, Bessis N . Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes. J Clin Immunol 2004; 24: 162\u2013169.","journal-title":"J Clin Immunol"},{"key":"BFgt2014115_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1089\/hum.2006.174","volume":"18","author":"M-C Boissier","year":"2007","unstructured":"Boissier M-C, Lemeiter D, Clavel C, Valvason C, Laroche L, Begue T et al. Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype. Hum Gene Ther 2007; 18: 525\u2013535.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/hum.2013.005","volume":"24","author":"L Samaranch","year":"2013","unstructured":"Samaranch L, Salegio E a, San Sebastian W, Kells AP, Bringas JR, Forsayeth J et al. Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Hum Gene Ther 2013; 24: 526\u2013532.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ymthe.2003.12.005","volume":"9","author":"LM Sanftner","year":"2004","unstructured":"Sanftner LM, Suzuki BM, Doroudchi MM, Feng L, McClelland A, Forsayeth JR et al. Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV. Mol Ther 2004; 9: 403\u2013409.","journal-title":"Mol Ther"},{"key":"BFgt2014115_CR36","first-page":"1760","volume":"14","author":"Q Li","year":"2008","unstructured":"Li Q, Miller R, Han P-Y, Pang J, Dinculescu A, Chiodo V et al. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Mol Vis 2008; 14: 1760\u20131769.","journal-title":"Mol Vis"},{"key":"BFgt2014115_CR37","doi-asserted-by":"publisher","first-page":"21ra16","DOI":"10.1126\/scitranslmed.3000659","volume":"2","author":"D Amado","year":"2010","unstructured":"Amado D, Mingozzi F, Hui D, Bennicelli JL, Wei Z, Chen Y et al. Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness. Sci Transl Med 2010; 2: 21ra16.","journal-title":"Sci Transl Med"},{"key":"BFgt2014115_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2174\/156652311796150354","volume":"11","author":"F Mingozzi","year":"2011","unstructured":"Mingozzi F, High KA . Immune responses to AAV in clinical trials. Curr Gene Ther 2011; 11: 321\u2013330.","journal-title":"Curr Gene Ther"},{"key":"BFgt2014115_CR39","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1128\/JVI.72.12.9795-9805.1998","volume":"72","author":"CL Halbert","year":"1998","unstructured":"Halbert CL, Standaert TA, Wilson CB, Miller AD . Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998; 72: 9795\u20139805.","journal-title":"J Virol"},{"key":"BFgt2014115_CR40","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2006-04-017913","volume":"108","author":"H Jiang","year":"2006","unstructured":"Jiang H, Couto LB, Patarroyo-White S, Liu T, Nagy D, Vargas JA et al. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy. Blood 2006; 108: 3321\u20133328.","journal-title":"Blood"},{"key":"BFgt2014115_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/hum.1998.9.4-477","volume":"9","author":"WC Manning","year":"1998","unstructured":"Manning WC, Zhou S, Bland MP, Escobedo JA, Dwarki V . Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Hum Gene Ther 1998; 9: 477\u2013485.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/jgm.885","volume":"8","author":"SWJ McPhee","year":"2006","unstructured":"McPhee SWJ, Janson CG, Li C, Samulski RJ, Camp a S, Francis J et al. Immune responses to AAV in a phase I study for Canavan disease. J Gene Med 2006; 8: 577\u2013588.","journal-title":"J Gene Med"},{"key":"BFgt2014115_CR43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","volume":"124","author":"M Jessup","year":"2011","unstructured":"Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B et al. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 2011; 124: 304\u2013313.","journal-title":"Circulation"},{"key":"BFgt2014115_CR44","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1523\/JNEUROSCI.4438-13.2014","volume":"34","author":"L Yin","year":"2014","unstructured":"Yin L, Masella B, Dalkara D, Zhang J, Flannery JG, Schaffer DV et al. Imaging light responses of foveal ganglion cells in the living macaque eye. J Neurosci 2014; 34: 6596\u20136605.","journal-title":"J Neurosci"},{"key":"BFgt2014115_CR45","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1167\/iovs.10-6250","volume":"52","author":"L Yin","year":"2011","unstructured":"Yin L, Greenberg K, Hunter JJ, Dalkara D, Kolstad KD, Masella BD et al. Intravitreal injection of AAV2 transduces macaque inner retina. Invest Ophthalmol Vis Sci 2011; 52: 2775\u20132783.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt2014115_CR46","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1073\/pnas.0802866105","volume":"105","author":"L Zhong","year":"2008","unstructured":"Zhong L, Li B, Mah CS, Govindasamy L, Agbandje-McKenna M, Cooper M et al. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Natl Acad Sci USA 2008; 105: 7827\u20137832.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2014115_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1046-2023(02)00232-3","volume":"28","author":"KRG Martin","year":"2002","unstructured":"Martin KRG, Klein RL, Quigley HA . Gene delivery to the eye using adeno-associated viral vectors. Methods 2002; 28: 267\u2013275.","journal-title":"Methods"},{"key":"BFgt2014115_CR48","first-page":"2224","volume":"38","author":"LM Hoffman","year":"1997","unstructured":"Hoffman LM, Maguire AM, Bennett J . Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci 1997; 38: 2224\u20132233.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt2014115_CR49","first-page":"862","volume":"19","author":"WE Benson","year":"1988","unstructured":"Benson WE, Brown GC, Tasman W, McNamara JA . Complications of vitrectomy for non-clearing vitreous hemorrhage in diabetic patients. Ophthalmic Surg 1988; 19: 862\u2013864.","journal-title":"Ophthalmic Surg"},{"key":"BFgt2014115_CR50","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1128\/JVI.74.3.1524-1532.2000","volume":"74","author":"CL Halbert","year":"2000","unstructured":"Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD . Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000; 74: 1524\u20131532.","journal-title":"J Virol"},{"key":"BFgt2014115_CR51","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1128\/JVI.78.12.6344-6359.2004","volume":"78","author":"CS Peden","year":"2004","unstructured":"Peden CS, Burger C, Muzyczka N, Mandel RJ . Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J Virol 2004; 78: 6344\u20136359.","journal-title":"J Virol"},{"key":"BFgt2014115_CR52","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.73.5.3994-4003.1999","volume":"73","author":"W Xiao","year":"1999","unstructured":"Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM . Gene Therapy Vectors Based on Adeno-Associated Virus Type 1. J Virol 1999; 73: 3994\u20134003.","journal-title":"J Virol"},{"key":"BFgt2014115_CR53","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"G-P Gao","year":"2002","unstructured":"Gao G-P, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM . Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854\u201311859.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2014115_CR54","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/hum.2011.202","volume":"23","author":"K Nieto","year":"2012","unstructured":"Nieto K, Stahl-Hennig C, Leuchs B, M\u00fcller M, Gissmann L, Kleinschmidt JA . Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques. Hum Gene Ther 2012; 23: 733\u2013741.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR55","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","volume":"78","author":"G Gao","year":"2004","unstructured":"Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol 2004; 78: 6381\u20136388.","journal-title":"J Virol"},{"key":"BFgt2014115_CR56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1128\/JVI.73.2.939-947.1999","volume":"73","author":"U Bantel-Schaal","year":"1999","unstructured":"Bantel-Schaal U, Delius H, Schmidt R, zur Hausen H . Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol 1999; 73: 939\u2013947.","journal-title":"J Virol"},{"key":"BFgt2014115_CR57","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1089\/hum.2008.033","volume":"19","author":"J Lin","year":"2008","unstructured":"Lin J, Calcedo R, Vandenberghe LH, Figueredo JM, Wilson JM . Impact of preexisting vector immunity on the efficacy of adeno-associated virus-based HIV-1 Gag vaccines. Hum Gene Ther 2008; 19: 663\u2013669.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR58","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1128\/jvi.71.8.5932-5941.1997","volume":"71","author":"CL Halbert","year":"1997","unstructured":"Halbert CL, Standaert TA, Aitken ML, Alexander IE, Russell DW, Miller AD . Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol 1997; 71: 5932\u20135941.","journal-title":"J Virol"},{"key":"BFgt2014115_CR59","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1089\/hum.2011.031","volume":"22","author":"L Wang","year":"2011","unstructured":"Wang L, Calcedo R, Bell P, Lin J, Grant RL, Siegel DL et al. Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors. Hum Gene Ther 2011; 22: 1389\u20131401.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.atherosclerosissup.2010.03.004","volume":"11","author":"D Gaudet","year":"2010","unstructured":"Gaudet D, de Wal J, Tremblay K, D\u00e9ry S, van Deventer S, Freidig A et al. Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency. Atheroscler Suppl 2010; 11: 55\u201360.","journal-title":"Atheroscler Suppl"},{"key":"BFgt2014115_CR61","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1210\/jc.2011-3002","volume":"97","author":"AC Carpentier","year":"2012","unstructured":"Carpentier AC, Frisch F, Labb\u00e9 SM, Gagnon R, de Wal J, Greentree S et al. Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients. J Clin Endocrinol Metab 2012; 97: 1635\u20131644.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFgt2014115_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fimmu.2013.00261","volume":"4","author":"K Willett","year":"2013","unstructured":"Willett K, Bennett J . Immunology of AAV-Mediated Gene Transfer in the Eye. Front Immunol 2013; 4: 261.","journal-title":"Front Immunol"},{"key":"BFgt2014115_CR63","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1002\/eji.200425022","volume":"34","author":"Y De Kozak","year":"2004","unstructured":"De Kozak Y, Andrieux K, Villarroya H, Klein C, Thillaye-Goldenberg B, Naud M-C et al. Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis. Eur J Immunol 2004; 34: 3702\u20133712.","journal-title":"Eur J Immunol"},{"key":"BFgt2014115_CR64","first-page":"316","volume":"30","author":"J Van der Voet","year":"1989","unstructured":"Van der Voet J, Liem A, Otto A, Kijlstra A . Intraocular antibody synthesis during experimental uveitis. Invest Ophthalmol Vis Sci 1989; 30: 316\u2013322.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt2014115_CR65","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1038\/sj.gt.3302123","volume":"10","author":"NA Huttner","year":"2003","unstructured":"Huttner NA, Girod A, Perabo L, Edbauer D, Kleinschmidt JA, B\u00fcning H et al. Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Ther 2003; 10: 2139\u20132147.","journal-title":"Gene Ther"},{"key":"BFgt2014115_CR66","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/hum.2009.194","volume":"21","author":"KD Kolstad","year":"2010","unstructured":"Kolstad KD, Dalkara D, Guerin K, Visel M, Hoffmann N, Schaffer DV et al. Changes in adeno-associated virus-mediated gene delivery in retinal degeneration. Hum Gene Ther 2010; 21: 571\u2013578.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014115_CR67","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/glia.22617","volume":"62","author":"O Vacca","year":"2014","unstructured":"Vacca O, Darche M, Schaffer D V, Flannery JG, Sahel J-A, Rendon A et al. AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers. Glia 2014; 62: 468\u2013476.","journal-title":"Glia"},{"key":"BFgt2014115_CR68","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nbt1182","volume":"24","author":"N Maheshri","year":"2006","unstructured":"Maheshri N, Koerber JT, Kaspar BK, Schaffer DV . Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat Biotechnol 2006; 24: 198\u2013204.","journal-title":"Nat Biotechnol"},{"key":"BFgt2014115_CR69","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/mt.2008.167","volume":"16","author":"JT Koerber","year":"2008","unstructured":"Koerber JT, Jang J-H, Schaffer DV . DNA shuffling of adeno-associated virus yields functionally diverse viral progeny. Mol Ther 2008; 16: 1703\u20131709.","journal-title":"Mol Ther"},{"key":"BFgt2014115_CR70","first-page":"S140","volume-title":"American Society of Gene and Cell Therapy\u2019s 15th Annual Meeting","author":"MA Bartel","year":"2012","unstructured":"Bartel MA, Hwang B-Y, Stone D, Koerber JT, Couto L, Mingozzi F et al. Directed evolution of aav for enhanced evasion of human neutralizing antibodies. American Society of Gene and Cell Therapy\u2019s 15th Annual Meeting 2012: Philadelphia, PA, USA S140."},{"key":"BFgt2014115_CR71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jgm.849","volume":"8","author":"L Perabo","year":"2006","unstructured":"Perabo L, Endell J, King S, Lux K, Goldnau D, Hallek M et al. Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus. J Gene Med 2006; 8: 155\u2013162.","journal-title":"J Gene Med"},{"key":"BFgt2014115_CR72","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1128\/JVI.00254-08","volume":"82","author":"D Grimm","year":"2008","unstructured":"Grimm D, Lee JS, Wang L, Desai T, Akache B, Storm TA et al. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J Virol 2008; 82: 5887\u20135911.","journal-title":"J Virol"},{"key":"BFgt2014115_CR73","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1128\/JVI.80.2.821-834.2006","volume":"80","author":"MA Lochrie","year":"2006","unstructured":"Lochrie MA, Tatsuno GP, Christie B, McDonnell JW, Zhou S, Surosky R et al. Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization. J Virol 2006; 80: 821\u2013834.","journal-title":"J Virol"},{"key":"BFgt2014115_CR74","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1128\/JVI.74.4.1761-1766.2000","volume":"74","author":"M Moskalenko","year":"2000","unstructured":"Moskalenko M, Chen L, van Roey M, Donahue BA, Snyder RO, McArthur JG et al. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J Virol 2000; 74: 1761\u20131766.","journal-title":"J Virol"},{"key":"BFgt2014115_CR75","doi-asserted-by":"publisher","first-page":"9281","DOI":"10.1128\/JVI.74.19.9281-9293.2000","volume":"74","author":"CE Wobus","year":"2000","unstructured":"Wobus CE, H\u00fcgle-D\u00f6rr B, Girod A, Petersen G, Hallek M, Kleinschmidt JA . Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J Virol 2000; 74: 9281\u20139293.","journal-title":"J Virol"},{"key":"BFgt2014115_CR76","doi-asserted-by":"publisher","first-page":"194ra92","DOI":"10.1126\/scitranslmed.3005795","volume":"5","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi F, Anguela XM, Pavani G, Chen Y, Davidson RJ, Hui DJ et al. Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci Transl Med 2013; 5: 194ra92.","journal-title":"Sci Transl Med"},{"key":"BFgt2014115_CR77","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1073\/pnas.0813365106","volume":"106","author":"KJD Excoffon","year":"2009","unstructured":"Excoffon KJD, Koerber JT, Dickey DD, Murtha M, Keshavjee S, Kaspar BK et al. Directed evolution of adeno-associated virus to an infectious respiratory virus. Proc Natl Acad Sci USA 2009; 106: 3865\u20133870.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2014115_CR78","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.exer.2013.11.001","volume":"119","author":"JM Strazzeri","year":"2014","unstructured":"Strazzeri JM, Hunter JJ, Masella BD, Yin L, Fischer WS, DiLoreto DA et al. Focal damage to macaque photoreceptors produces persistent visual loss. Exp Eye Res 2014; 119: 88\u201396.","journal-title":"Exp Eye Res"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2014115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2014115","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2014115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:12:12Z","timestamp":1648555932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2014115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,11]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFgt2014115"],"URL":"https:\/\/doi.org\/10.1038\/gt.2014.115","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,11]]},"assertion":[{"value":"11 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MAK, JGF and DVS are inventors on patents related to engineering of adeno-associated viruses, and MAK and DVS are associated with a company (4D Molecular Therapeutics) involved in AAV vector engineering.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}